Old Web
English
Sign In
Acemap
>
Paper
>
P-230Second line FOLFOX4 and bevacizumab for metastatic colorectal cancer: Real life efficacy and predictive factors
P-230Second line FOLFOX4 and bevacizumab for metastatic colorectal cancer: Real life efficacy and predictive factors
2018
T. Lewandowski
R. Biernacka
M. Chmielowiec
M Gryziak
Keywords:
Bevacizumab
General surgery
Medicine
Colorectal cancer
second line
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]